Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Artivion, Inc. - SIC # 8070 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AORT
New York
8070
artivion.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Artivion, Inc.
The 5 Most Interesting Analyst Questions From Artivion’s Q1 Earnings Call
- Jun 26th, 2025 3:50 pm
Artivion to Participate in Upcoming Investor Conferences
- Jun 3rd, 2025 2:10 pm
Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
- May 28th, 2025 3:51 pm
Returns On Capital At Artivion (NYSE:AORT) Have Stalled
- May 25th, 2025 6:48 am
Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
- May 14th, 2025 2:01 pm
Artivion Reports First Quarter 2025 Financial Results
- May 5th, 2025 2:05 pm
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting
- May 5th, 2025 5:00 am
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
- Apr 21st, 2025 2:10 pm
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year
- Apr 14th, 2025 6:58 am
Do Options Traders Know Something About Artivion (AORT) Stock We Don't?
- Mar 24th, 2025 10:20 am
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
- Mar 4th, 2025 2:05 pm
Artivion Full Year 2024 Earnings: EPS Misses Expectations
- Mar 4th, 2025 3:31 am
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround
- Feb 27th, 2025 7:35 am
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts
- Feb 27th, 2025 3:54 am
Artivion price target lowered to $32 from $34 at Needham
- Feb 26th, 2025 8:01 am
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
- Feb 24th, 2025 2:05 pm
Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26?
- Feb 24th, 2025 10:22 am
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results
- Feb 10th, 2025 2:10 pm
Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)
- Feb 4th, 2025 3:17 am
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
- Jan 27th, 2025 6:00 am
Scroll